FDA Inspection
Sant P. Chawla, MDSant P. Chawla, MD – FDA Inspection, Apr 15, 2022
Record Details
This FDA Inspection record concerns Sant P. Chawla, MD, with an inspection on April 15, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sant P. Chawla, MD
- Inspection Date
- April 15, 2022
- Product Type
- Drugs
View Company Profile
ID · fc9ea0cd-7118-4192-be16-3f8f20ae2c42
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1167324
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sant P. Chawla, MD
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2026 | Not classified | Los Angeles District Office | Bioresearch Monitoring |
| October 13, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 13, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 30, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 29, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sant P. Chawla, MD
- FDA Inspection 1324454 - 2026-06-30
- FDA Inspection 945678 - 2015-10-13
- FDA Inspection 757044 - 2011-12-13
- FDA Inspection 757043 - 2011-11-30
- FDA Inspection 722028 - 2011-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.